• Health & Medicine

Reprogrammed oestrogen binding linked to more aggressive breast cancer

Scientists based at Cancer Research UK's Cambridge Research Institute have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients who are more likely to relapse, according to a study published in Nature today (Wednesday). Scientists based at Cancer Research UK's Cambridge Research Institute have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients who are more likely to relapse, according to a study published in Nature today (Wednesday).

4 January 2012

• Health & Medicine

First patients enrolled in project to improve NHS cancer gene testing

Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies. Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies.

21 November 2011

• Health & Medicine

Researchers trial new drug for women with hereditary breast and ovarian cancer

A Cancer Research UK-funded trial of a new drug for patients with advanced breast or ovarian cancer due to inherited gene faults has been launched at the Oxford Experimental Cancer Medicine Centre (ECMC) at the University of Oxford. A Cancer Research UK-funded trial of a new drug for patients with advanced breast or ovarian cancer due to inherited gene faults has been launched at the Oxford Experimental Cancer Medicine Centre (ECMC) at the University of Oxford.

17 August 2011

• Health & Medicine

Charity leads world in helping cancer patients get the right treatment

Cancer Research UK's chief executive Harpal Kumar today spoke of a 'golden era' for cancer research as the UK is poised to lead the world in individualising the practice of medicine by understanding which treatments are best suited to an individual patient's particular genetic type of cancer. Cancer Research UK's chief executive Harpal Kumar today spoke of a 'golden era' for cancer research as the UK is poised to lead the world in individualising the practice of medicine by understanding which treatments are best suited to an individual patient's particular genetic type of cancer.

15 June 2011

• Health & Medicine

Gene fault could predict ovarian cancer drug success

Faults in a gene commonly inactivated in many different types of cancer could be used to predict which drug combination ovarian cancer patients are most likely to benefit from, according to results presented at the American Society for Clinical Oncology today. Faults in a gene commonly inactivated in many different types of cancer could be used to predict which drug combination ovarian cancer patients are most likely to benefit from, according to results presented at the American Society for Clinical Oncology today.

6 June 2011

• Health & Medicine

5m grant to advance personalised treatments for kidney cancer

An international consortium led by scientists from the Cancer Research UK London Research Institute, The Royal Marsden Hospital and the Technical University of Denmark has been granted nearly Ј5million (5.8 million Euros) by the European Union to identify gene targets for personalised treatment for kidney cancer patients. An international consortium led by scientists from the Cancer Research UK London Research Institute, The Royal Marsden Hospital and the Technical University of Denmark has been granted nearly Ј5million (5.8 million Euros) by the European Union to identify gene targets for personalised treatment for kidney cancer patients.

18 March 2011

• Health & Medicine

Scientists discover first breast cancer 'oncogene' for five years

Cancer Research UK scientists have pinpointed a key cancer-causing gene that, when overactive, triggers a particularly aggressive type of breast cancer to develop. Cancer Research UK scientists have pinpointed a key cancer-causing gene that, when overactive, triggers a particularly aggressive type of breast cancer to develop.

18 February 2011

• Health & Medicine

AstraZeneca and Pfizer join Cancer Research UK's Stratified Medicine Programme

Cancer Research UK will be supported by AstraZeneca and Pfizer in a multimillion pound initiative to examine how genetic tests to improve cancer diagnosis can be best rolled out across the NHS. Cancer Research UK will be supported by AstraZeneca and Pfizer in a multimillion pound initiative to examine how genetic tests to improve cancer diagnosis can be best rolled out across the NHS.

1 February 2011

• Health & Medicine

Multimillion pound project launched to improve genetic testing for cancer drugs

Cancer Research UK has launched a multimillion pound programme, alongside the Technology Strategy Board's Innovation Platform, to help turn the genetic revolution into better treatment for cancer patients. Cancer Research UK has launched a multimillion pound programme, alongside the Technology Strategy Board's Innovation Platform, to help turn the genetic revolution into better treatment for cancer patients.

13 October 2010